Long-Term Use of Tafamidis in Transthyretin Familial Amyloid Polyneuropathy: A Single Center Experience

被引：0
|
作者：
Coelho, Teresa [1 ]
Silva, Ana [1 ]
Maia, Luis [1 ]
Mandel, Francine [2 ]
Rosas, Gregory [2 ]
Karayal, Onur [2 ]
机构：
[1] Hosp Santo Antonio, Oporto, Portugal
[2] Pfizer Inc, New York, NY USA
来源：
NEUROLOGY | 2013年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S58005
引用
收藏
页数：1
相关论文
共 50 条
  • [21] AN OBSERVATIONAL STUDY ON TAFAMIDIS FOR TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY IN ITALY
    Cortese, A.
    Russo, M.
    Obici, L.
    Cavallaro, T.
    Fabrizi, G. M.
    Manganelli, F.
    Santoro, L.
    Luigetti, M.
    Sabatelli, M.
    Schenone, A.
    Grandis, M.
    Mauro, A.
    Pradotto, L. G.
    Mazzeo, A.
    Gentile, L.
    Piscosquito, G.
    Calabrese, D.
    Vita, G.
    Merlini, G.
    Pareyson, D.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 : S8 - S9
  • [22] Tafamidis for a Transplant Patient with Transthyretin Amyloid Polyneuropathy
    Romero-Imbroda, Jesus
    Sagrario-Fustero, Teresa
    Del Canto-Perez, Clementine
    JOURNAL OF CLINICAL NEUROLOGY, 2017, 13 (04): : 444 - 446
  • [23] Long-term Survival Benefit of Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy
    Patel, Jignesh
    Elliott, Perry
    Gundapaneni, Balarama
    Li, Benjamin
    Sultan, Marla
    Grogan, Martha
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S64 - S65
  • [24] Long-term survival of 3000 transthyretin familial amyloid polyneuropathy patients over 100 years
    Ines, M.
    Coelho, T.
    Conceicao, I.
    Saramago, P.
    Carvalho, M.
    Costa, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 44 - 44
  • [25] Evaluation of one year treatment with tafamidis in Portuguese patients with transthyretin familial amyloid polyneuropathy
    Coelho, T.
    Conceicao, I.
    Cardoso, M.
    Monteiro, C.
    Alves, C.
    Rodrigues, C.
    Pereira, P.
    Silva, A. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 327 - 327
  • [26] Evaluation of one year treatment with tafamidis in Portuguese patients with transthyretin familial amyloid polyneuropathy
    Coelho, T.
    Conceicao, I.
    Cardoso, M.
    Monteiro, C.
    Alves, C.
    Rodrigues, C.
    Pereira, P.
    Silva, A. M.
    JOURNAL OF NEUROLOGY, 2014, 261 : S221 - S221
  • [27] Cardiovascular impact of tafamidis in familial amyloidotic polyneuropathy: experience of a center
    Brochado, B.
    Rodrigues, P.
    Sousa, M. J.
    Silveira, I.
    Santos, M.
    Coelho, T.
    Lagarto, V.
    Reis, H.
    Carvalho, H.
    Torres, S.
    EUROPEAN HEART JOURNAL, 2015, 36 : 275 - 275
  • [28] Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy
    Cruz, Marcia Waddington
    Amass, Leslie
    Keohane, Denis
    Schwartz, Jeffrey
    Li, Huihua
    Gundapaneni, Balarama
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2016, 23 (03): : 178 - 183
  • [29] Post Hoc Analysis of Nutritional Status in Patients with Transthyretin Familial Amyloid Polyneuropathy: Impact of Tafamidis
    Suhr O.B.
    Conceição I.M.
    Karayal O.N.
    Mandel F.S.
    Huertas P.E.
    Ericzon B.-G.
    Neurology and Therapy, 2014, 3 (2) : 101 - 112
  • [30] Sustainability of response to tafamidis, a disease-modifying therapy for transthyretin type familial amyloid polyneuropathy
    Coelho, T.
    Maia, L.
    Silva, A.
    Cruz, M. Waddington
    Plante-Bordeneuve, V.
    Suhr, O. B.
    Conceicao, I.
    Schmidt, H.
    Trigo, P.
    Packman, J.
    Grogan, D. R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 35 - 35
12345